Estimating influenza vaccine efficacy from challenge and community-based study data.

Area of Science:

• Immunology
• Vaccinology
• Epidemiology

Background:

• Influenza vaccines are crucial for public health, but their efficacy can be measured in various ways.
• Understanding different vaccine efficacy measures is essential for accurate assessment of vaccine performance.

Purpose of the Study:

• To estimate four distinct measures of vaccine efficacy for live attenuated and inactivated influenza vaccines.
• To propose a combined measure (VE(C)) for population-level transmission reduction.

Main Methods:

• Secondary analysis of 5 experimental influenza challenge studies in seronegative adults.
• Analysis of community-based vaccine trials to assess vaccine efficacy measures: VE(S), VE(P), VE(SP), and VE(I).

Main Results:

• Live and inactivated influenza vaccines demonstrated similar efficacy against laboratory-confirmed infection (VE(S)).
• Live vaccines showed higher efficacy against symptomatic illness given infection (VE(P)) than inactivated vaccines, though not statistically significant.
• Vaccine efficacy against infection and illness (VE(SP)) was higher for live vaccines.
• Vaccine efficacy against infectiousness (VE(I)) was low for both vaccine types.

Conclusions:

• Both live and inactivated influenza vaccines can maintain high VE(SP) and VE(C) even with low VE(I), provided other efficacy measures are robust.
• The study highlights the importance of considering multiple efficacy measures for a comprehensive understanding of influenza vaccine performance.